HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ACTL6B
actin like 6B
Chromosome 7 Β· 7q22.1
NCBI Gene: 51412Ensembl: ENSG00000077080.11HGNC: HGNC:160UniProt: O94805
63PubMed Papers
22Diseases
0Drugs
54Pathogenic Variants
FUNCTIONAL ROLE
Hub GeneTranscription Factor
RESEARCH IMPACT
Variant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
SWI/SNF complexneuron maturationchromatin remodelingnucleusgenetic developmental and epileptic encephalopathyintellectual developmental disorder with severe speech and ambulation defectsautosomal dominant non-syndromic intellectual disabilityautism spectrum disorder
✦AI Summary

ACTL6B encodes a component of the neuron-specific chr7 remodeling BAF complex (nBAF) that plays critical roles in postmitotic neural development and dendrite formation 1. The protein functions in ATP-dependent chr7 remodeling by altering DNA-nucleosome topology to regulate gene transcription 1. During neural development, ACTL6B expression increases as neural progenitors differentiate into neurons, where it becomes essential for dendrite development and neuronal maturation 1. The nBAF complex containing ACTL6B normally represses early response genes, and loss of ACTL6B function leads to inappropriate activation of AP1 transcription factors and disrupted chr7 accessibility 2. Recent evidence suggests ACTL6B also functions in the nucleolus where it plays a crucial role in ribosome biogenesis, particularly pre-rRNA processing, expanding its role beyond chr7 remodeling 3. Pathogenic variants in ACTL6B cause two distinct disorders: biallelic loss-of-function mutations lead to severe developmental and epileptic encephalopathy 76 (DEE76) with profound intellectual disability, intractable seizures, and brain abnormalities 45, while de novo heterozygous mutations cause a milder autosomal dominant disorder with moderate intellectual disability and speech deficits 13. Patient-derived neurons demonstrate impaired dendrite development, dysregulated gene expression, and neuronal hyperexcitability 16.

Sources cited
1
ACTL6B is essential for dendrite development and neuronal maturation, with knockout causing profound dendrite deficits
PMID: 31031012
2
ACTL6B normally represses early response genes and loss leads to inappropriate gene activation and autism-related behaviors
PMID: 32312822
3
ACTL6B functions in nucleolar ribosome biogenesis and pre-rRNA processing, suggesting ribosomopathy mechanism
PMID: 39275948
4
Biallelic ACTL6B mutations cause severe developmental and epileptic encephalopathy with brain abnormalities
PMID: 30656450
5
DEE76 is characterized by early-onset drug-refractory epilepsy, global developmental delay, and brain myelination defects
PMID: 36553410
6
Patient-derived neurons show reduced ACTL6B protein stability, dysregulated gene expression, and neuronal hyperexcitability
PMID: 33141462
Disease Associationsβ“˜22
genetic developmental and epileptic encephalopathyOpen Targets
0.69Moderate
intellectual developmental disorder with severe speech and ambulation defectsOpen Targets
0.66Moderate
autosomal dominant non-syndromic intellectual disabilityOpen Targets
0.55Moderate
autism spectrum disorderOpen Targets
0.50Moderate
early-infantile DEEOpen Targets
0.46Moderate
genetic disorderOpen Targets
0.41Moderate
Intellectual disabilityOpen Targets
0.41Moderate
complex neurodevelopmental disorderOpen Targets
0.37Weak
undetermined early-onset epileptic encephalopathyOpen Targets
0.37Weak
autismOpen Targets
0.34Weak
Global developmental delayOpen Targets
0.27Weak
congenital generalized lipodystrophy type 2Open Targets
0.27Weak
metabolic syndromeOpen Targets
0.07Suggestive
Female infertility due to fertilization defectOpen Targets
0.07Suggestive
deafnessOpen Targets
0.06Suggestive
oocyte maturation defect 14Open Targets
0.06Suggestive
oocyte maturation defect 5Open Targets
0.06Suggestive
female infertility due to oocyte meiotic arrestOpen Targets
0.06Suggestive
Hydatidiform MoleOpen Targets
0.05Suggestive
autosomal recessive nonsyndromic hearing loss 9Open Targets
0.05Suggestive
Developmental and epileptic encephalopathy 76UniProt
Intellectual developmental disorder with severe speech and ambulation defectsUniProt
Pathogenic Variants54
NM_016188.5(ACTL6B):c.556C>T (p.Gln186Ter)Pathogenic
Developmental and epileptic encephalopathy, 76|ACTL6B-related recessive epilepsy
β˜…β˜…β˜†β˜†2025β†’ Residue 186
NM_016188.5(ACTL6B):c.1027G>A (p.Gly343Arg)Pathogenic
Intellectual developmental disorder with severe speech and ambulation defects|Autism;ACTL6B-related dominant intellectual disability|Intellectual disability|ACTL6B-related BAFopathy|not provided|Inborn genetic diseases
β˜…β˜…β˜†β˜†2025β†’ Residue 343
NM_016188.5(ACTL6B):c.289C>T (p.Arg97Ter)Likely pathogenic
Developmental and epileptic encephalopathy, 76|ACTL6B-related recessive epilepsy|Intellectual developmental disorder with severe speech and ambulation defects
β˜…β˜…β˜†β˜†2024β†’ Residue 97
NM_016188.5(ACTL6B):c.740G>A (p.Trp247Ter)Likely pathogenic
Developmental and epileptic encephalopathy, 76|not provided|ACTL6B-related recessive epilepsy|ACTL6B-related disorder
β˜…β˜…β˜†β˜†2021β†’ Residue 247
NM_016188.5(ACTL6B):c.892C>T (p.Arg298Ter)Pathogenic
Autism spectrum disorder|not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 298
NM_016188.5(ACTL6B):c.1111C>G (p.Pro371Ala)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 371
NM_016188.5(ACTL6B):c.1112C>T (p.Pro371Leu)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2025β†’ Residue 371
NM_016188.5(ACTL6B):c.149del (p.Gly50fs)Pathogenic
Developmental and epileptic encephalopathy, 76
β˜…β˜†β˜†β˜†2025β†’ Residue 50
NM_016188.5(ACTL6B):c.990_993delinsAGCA (p.Gly331Ala)Likely pathogenic
Intellectual developmental disorder with severe speech and ambulation defects
β˜…β˜†β˜†β˜†2025β†’ Residue 331
NM_016188.5(ACTL6B):c.1113+1G>TLikely pathogenic
Congenital generalized lipodystrophy type 2
β˜…β˜†β˜†β˜†2024
NM_016188.5(ACTL6B):c.604C>T (p.Gln202Ter)Pathogenic
Developmental and epileptic encephalopathy, 76
β˜…β˜†β˜†β˜†2024β†’ Residue 202
NM_016188.5(ACTL6B):c.370-2A>GLikely pathogenic
not provided
β˜…β˜†β˜†β˜†2024
NM_016188.5(ACTL6B):c.1112C>G (p.Pro371Arg)Pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 371
NM_016188.5(ACTL6B):c.37del (p.Ala13fs)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2024β†’ Residue 13
NM_016188.5(ACTL6B):c.1120C>T (p.Arg374Ter)Pathogenic
Developmental and epileptic encephalopathy, 76
β˜…β˜†β˜†β˜†2024β†’ Residue 374
NM_016188.5(ACTL6B):c.999T>A (p.Cys333Ter)Pathogenic
Developmental and epileptic encephalopathy, 76
β˜…β˜†β˜†β˜†2024β†’ Residue 333
NM_016188.5(ACTL6B):c.1121G>A (p.Arg374Gln)Likely pathogenic
not provided
β˜…β˜†β˜†β˜†2022β†’ Residue 374
NM_016188.5(ACTL6B):c.369+1G>CLikely pathogenic
Developmental and epileptic encephalopathy, 76
β˜…β˜†β˜†β˜†2022
NM_016188.5(ACTL6B):c.1027G>T (p.Gly343Trp)Likely pathogenic
Intellectual developmental disorder with severe speech and ambulation defects
β˜…β˜†β˜†β˜†2022β†’ Residue 343
NM_016188.5(ACTL6B):c.554T>C (p.Leu185Pro)Likely pathogenic
Intellectual developmental disorder with severe speech and ambulation defects
β˜…β˜†β˜†β˜†2022β†’ Residue 185
View on ClinVar β†—
Related Genes
DPF1Protein interaction100%SMARCC2Protein interaction99%SMARCB1Protein interaction99%DPF2Protein interaction98%ARID2Protein interaction97%SMARCD3Protein interaction97%
Tissue Expression6 tissues
Brain
100%
Liver
1%
Bone Marrow
0%
Ovary
0%
Heart
0%
Lung
0%
Gene Interaction Network
Click a node to explore
ACTL6BDPF1SMARCC2SMARCB1DPF2ARID2SMARCD3
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted Β· UniProt O94805
View on AlphaFold β†—
Constraintβ“˜
LOEUFβ“˜
0.95LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.75 [0.59–0.95]
RankingsWhere ACTL6B stands among ~20K protein-coding genes
  • #7,336of 20,598
    Most Researched63
  • #1,263of 5,498
    Most Pathogenic Variants54 Β· top quartile
  • #8,947of 17,882
    Most Constrained (LOEUF)0.95
Genes detectedACTL6B
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Autozygome and high throughput confirmation of disease genes candidacy.
PMID: 30237576
Genet Med Β· 2019
1.00
2
Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders.
PMID: 39275948
Genet Med Β· 2025
0.90
3
Mutations in ACTL6B Cause Neurodevelopmental Deficits and Epilepsy and Lead to Loss of Dendrites in Human Neurons.
PMID: 31031012
Am J Hum Genet Β· 2019
0.80
4
Mutations in ACTL6B, coding for a subunit of the neuron-specific chromatin remodeling complex nBAF, cause early onset severe developmental and epileptic encephalopathy with brain hypomyelination and cerebellar atrophy.
PMID: 30656450
Hum Genet Β· 2019
0.70
5
TDP-43 Cryptic RNAs in Perry Syndrome: Differences across Brain Regions and TDP-43 Proteinopathies.
PMID: 39788898
Mov Disord Β· 2025
0.60